Global and Region Oral Anticoagulant Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Oral Anticoagulant market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Oral Anticoagulantmarket, defines the market attractiveness level of Oral Anticoagulant market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Oral Anticoagulant industry, describes the types of Oral Anticoagulant market, the applications of major players and the market size, and deeply analyzes the current situation of the global Oral Anticoagulant market and the development prospects and opportunities of Oral Anticoagulant industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Oral Anticoagulant market in Chapter 13.

    By Player:

    • Novartis AG

    • Akers Biosciences

    • GlaxoSmithKline

    • AstraZeneca

    • Eli Lilly

    • Medicure

    • Eisai

    • Sanofi

    • Pfizer

    By Type:

    • Warfarin

    • Dabigatran

    • Rivaroxaban

    • Others

    By End-User:

    • Thromboembolic Disease

    • Disseminated Intravascular Coagulation

    • Cardiovascular Surgery

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Oral Anticoagulant Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Oral Anticoagulant Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Oral Anticoagulant Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Oral Anticoagulant Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Oral Anticoagulant Market Analysis and Outlook to 2022

    • 7.1 Global Oral Anticoagulant Consumption (2017-2022)

    • 7.2 United States Oral Anticoagulant Consumption (2017-2022)

    • 7.3 Europe Oral Anticoagulant Consumption (2017-2022)

    • 7.4 China Oral Anticoagulant Consumption (2017-2022)

    • 7.5 Japan Oral Anticoagulant Consumption (2017-2022)

    • 7.6 India Oral Anticoagulant Consumption (2017-2022)

    • 7.7 South Korea Oral Anticoagulant Consumption (2017-2022)

    8 Region and Country-wise Oral Anticoagulant Market Analysis and Outlook to 2028

    • 8.1 Global Oral Anticoagulant Consumption Forecast (2022-2028)

    • 8.2 United States Oral Anticoagulant Consumption Forecast (2022-2028)

    • 8.3 Europe Oral Anticoagulant Consumption Forecast (2022-2028)

    • 8.4 China Oral Anticoagulant Consumption Forecast (2022-2028)

    • 8.5 Japan Oral Anticoagulant Consumption Forecast (2022-2028)

    • 8.6 India Oral Anticoagulant Consumption Forecast (2022-2028)

    • 8.7 South Korea Oral Anticoagulant Consumption Forecast (2022-2028)

    9 Global Oral Anticoagulant Market Outlook by Types and Applications to 2022

    • 9.1 Global Oral Anticoagulant Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Warfarin Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Dabigatran Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Rivaroxaban Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Oral Anticoagulant Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Thromboembolic Disease Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Disseminated Intravascular Coagulation Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Cardiovascular Surgery Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Oral Anticoagulant Market Outlook by Types and Applications to 2028

    • 10.1 Global Oral Anticoagulant Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Warfarin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Dabigatran Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Rivaroxaban Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Oral Anticoagulant Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Thromboembolic Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Disseminated Intravascular Coagulation Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Cardiovascular Surgery Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Oral Anticoagulant Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Oral Anticoagulant Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Oral Anticoagulant Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Oral Anticoagulant Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Oral Anticoagulant Market Competitive Analysis

    • 14.1 Novartis AG

      • 14.1.1 Novartis AG Company Details

      • 14.1.2 Novartis AG Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Novartis AG Oral Anticoagulant Product and Service

    • 14.2 Akers Biosciences

      • 14.2.1 Akers Biosciences Company Details

      • 14.2.2 Akers Biosciences Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Akers Biosciences Oral Anticoagulant Product and Service

    • 14.3 GlaxoSmithKline

      • 14.3.1 GlaxoSmithKline Company Details

      • 14.3.2 GlaxoSmithKline Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 GlaxoSmithKline Oral Anticoagulant Product and Service

    • 14.4 AstraZeneca

      • 14.4.1 AstraZeneca Company Details

      • 14.4.2 AstraZeneca Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 AstraZeneca Oral Anticoagulant Product and Service

    • 14.5 Eli Lilly

      • 14.5.1 Eli Lilly Company Details

      • 14.5.2 Eli Lilly Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Eli Lilly Oral Anticoagulant Product and Service

    • 14.6 Medicure

      • 14.6.1 Medicure Company Details

      • 14.6.2 Medicure Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Medicure Oral Anticoagulant Product and Service

    • 14.7 Eisai

      • 14.7.1 Eisai Company Details

      • 14.7.2 Eisai Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Eisai Oral Anticoagulant Product and Service

    • 14.8 Sanofi

      • 14.8.1 Sanofi Company Details

      • 14.8.2 Sanofi Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Sanofi Oral Anticoagulant Product and Service

    • 14.9 Pfizer

      • 14.9.1 Pfizer Company Details

      • 14.9.2 Pfizer Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Pfizer Oral Anticoagulant Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Oral Anticoagulant

    • Figure Oral Anticoagulant Picture

    • Table Global Oral Anticoagulant Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Oral Anticoagulant Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Oral Anticoagulant Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Oral Anticoagulant Consumption by Country (2017-2022)

    • Figure United States Oral Anticoagulant Consumption and Growth Rate (2017-2022)

    • Table Europe Oral Anticoagulant Consumption and Growth Rate (2017-2022)

    • Figure China Oral Anticoagulant Consumption and Growth Rate (2017-2022)

    • Figure Japan Oral Anticoagulant Consumption and Growth Rate (2017-2022)

    • Figure India Oral Anticoagulant Consumption and Growth Rate (2017-2022)

    • Figure South Korea Oral Anticoagulant Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Anticoagulant Consumption Forecast by Country (2022-2028)

    • Figure United States Oral Anticoagulant Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Oral Anticoagulant Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Oral Anticoagulant Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Oral Anticoagulant Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Oral Anticoagulant Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Oral Anticoagulant Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Warfarin Consumption and Growth Rate (2017-2022)

    • Figure Global Dabigatran Consumption and Growth Rate (2017-2022)

    • Figure Global Rivaroxaban Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Thromboembolic Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Disseminated Intravascular Coagulation Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiovascular Surgery Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Warfarin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dabigatran Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rivaroxaban Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Thromboembolic Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Disseminated Intravascular Coagulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiovascular Surgery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Oral Anticoagulant Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Oral Anticoagulant Export by Region (Top 5 Countries) (2017-2028)

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Oral Anticoagulant Product and Service

    • Table Akers Biosciences (Foundation Year, Company Profile and etc.)

    • Table Akers Biosciences Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

    • Table Akers Biosciences Oral Anticoagulant Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Oral Anticoagulant Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Oral Anticoagulant Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Oral Anticoagulant Product and Service

    • Table Medicure (Foundation Year, Company Profile and etc.)

    • Table Medicure Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medicure Oral Anticoagulant Product and Service

    • Table Eisai (Foundation Year, Company Profile and etc.)

    • Table Eisai Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai Oral Anticoagulant Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Oral Anticoagulant Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Oral Anticoagulant Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.